Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Therapeutics Announces FDA Approval Of Phase 2 Clinical Trial

Sept 5 (Reuters) - Nykode Therapeutics ASA  NYKD.OL :
    * ANNOUNCES FDA APPROVAL OF IND FOR VB-C-04, A TRIAL OF
VB10.16 IN
HPV16-POSITIVE CERVICAL CANCER
    * TO FURTHER ELABORATE ON TRIAL DESIGN AND DEVELOPMENT
STRATEGY AT
UPCOMING CAPITAL MARKETS DAY IN NEW YORK ON SEPTEMBER 20
    * IS ON TRACK TO INITIATE TRIAL IN Q4 OF 2023

Source text for Eikon:  ID:nObi4l9YTa 
Further company coverage:  NYKD.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Nykode Therapeutics ASA

See all news